Neurology News

Clonal hematopoiesis of indeterminate potential, which has been shown to substantially increase risk for blood cancer and cardiovascular disease, also appeared associated with protection from Alzheimer’s disease, according to study results.

Dual antiplatelet therapy that combined aspirin with either ticagrelor or clopidogrel outperformed aspirin alone in minor ischemic stroke and transient ischemic attack, according to results of a network meta-analysis.

Specialty epilepsy care availability increased in the U.S. following implementation of the National Association of Epilepsy Centers’ accreditation program, according to study results published in Neurology.

Men and women with ischemic stroke had improved functional outcomes in the past 2 decades, likely due in part to the development of acute reperfusion therapy, according to results of a prospective, registry cohort study.

Patients with COVID-19-associated disorders of consciousness who survived the infection were highly likely to regain consciousness, according to results of a prospective, multimodal study.

Asian, American Indian, Alaska Native, Latino and Hispanic patients are underrepresented in U.S. clinical trials for new drugs and biologics, compared with national census figures, according to a research letter published in JAMA.

Neurocrine Biosciences announced data from a phase 3 trial of Ingrezza that showed it reduced chorea severity among patients with Huntington’s disease.

A self-administered test detected mild cognitive impairment conversion to dementia at least 6 months sooner than the Mini-Mental State Examination, according to results of a cohort study published in Alzheimer’s Research & Therapy.

The Parkinson’s Foundation announced intentions to expand its clinical care network to include 60 Centers of Excellence globally.

Severe auditory dysfunction was a common neurobiological feature of neurofibromatosis type 1, according to results of a case-control study published in JAMA Network Open.